News
- Author:
- Mark S. Lesney, PhD
Publish date: August 10, 2021
A continuous-infusion of plasma-derived VWF concentrate provided adequate hemostasis in aVWD resulting from monoc...
News
- Author:
- Mark S. Lesney, PhD
Publish date: August 4, 2021
Recombinant factor IX Fc fusion protein (rFIXFc) was effective, both as prophylaxis and in the treatment of bleeding episodes in previously untreat...
News
- Author:
- Mark S. Lesney, PhD
Publish date: July 7, 2021
While half of the patients in the review did not have major bleeding (MB), the risk of dying was twofold higher i...
News
- Author:
- Mark S. Lesney, PhD
Publish date: June 9, 2021
Initial bleeding episodes were most commonly oropharyngeal, related to circumcision, or intracranial or extracran...
News
- Author:
- Mark S. Lesney, PhD
Publish date: June 8, 2021
Systemic review finds 80 years of age an important cutoff point for switching dosage.
News
- Author:
- Mark S. Lesney, PhD
Publish date: June 1, 2021
Rurioctocog alfa pegol prophylaxis to target 8%-12% FVIII troughs resulted in a higher proportion of people with ...
News
- Author:
- Mark S. Lesney, PhD
Publish date: May 18, 2021
A study showed the CNS relapse rate of patients with high-risk diffuse large B-cell lymphoma was not significantl...
News
- Author:
- Mark S. Lesney, PhD
Publish date: May 18, 2021
Pegcetacoplan (Empaveli) was approved as a treatment for paroxysmal nocturnal hemoglobinuria (PNH).
News
- Author:
- Mark S. Lesney, PhD
Publish date: May 11, 2021
Across four clinical profile categories, all-cause total costs, medical costs, and pharmacy costs were significan...
News
- Author:
- Mark S. Lesney, PhD
Publish date: May 4, 2021
There is high variability in hemophilia chronic pain definitions, samples, and assessment methods, as well as a w...
News
- Author:
- Mark S. Lesney, PhD
Publish date: April 23, 2021
Genetic analysis showed that the mitochondrial biogenesis gene PGC1A may have a possible role in increasing mtDNA...
News
- Author:
- Mark S. Lesney, PhD
Publish date: April 22, 2021
Among t-AML patients who underwent HSCT, a significant decrease in survival was associated with an increasing num...
News
- Author:
- Mark S. Lesney, PhD
Publish date: April 19, 2021
The overall prevalence of CLL and COVID-19 concurrence was around 0.6%, according to the review.
News
- Author:
- Mark S. Lesney, PhD
Publish date: April 16, 2021
The new drug has shown the ability to stimulate blood cells to produce fetal hemoglobin at levels predicted to pr...
News
- Author:
- Mark S. Lesney, PhD
Publish date: April 14, 2021
Treatment choices based on new tools such as the Comprehensive Geriatric Assessment can provide useful guidance b...
